Cargando…

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Biernacka, J M, Sangkuhl, K, Jenkins, G, Whaley, R M, Barman, P, Batzler, A, Altman, R B, Arolt, V, Brockmöller, J, Chen, C H, Domschke, K, Hall-Flavin, D K, Hong, C J, Illi, A, Ji, Y, Kampman, O, Kinoshita, T, Leinonen, E, Liou, Y J, Mushiroda, T, Nonen, S, Skime, M K, Wang, L, Baune, B T, Kato, M, Liu, Y L, Praphanphoj, V, Stingl, J C, Tsai, S J, Kubo, M, Klein, T E, Weinshilboum, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314112/ https://www.ncbi.nlm.nih.gov/pubmed/27801898 http://dx.doi.org/10.1038/tp.2016.187

Ejemplares similares

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2015)

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
por: Amare, Azmeraw T., et al.
Publicado: (2018)

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics
por: Gupta, M, et al.
Publicado: (2016)

ISPCS conference 03.10.18
por: Lavy, Rachel Tessa, et al.
Publicado: (2018)

ISPCS conference 01.10.2018
por: Lavy, Rachel Tessa, et al.
Publicado: (2018)

Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics
por: Liu, Duan, et al.
Publicado: (2018)

Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study
por: Schiele, M A, et al.
Publicado: (2020)

Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate
por: Karpyak, V M, et al.
Publicado: (2014)

Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression
por: Godlewska, B R, et al.
Publicado: (2016)

Detecting Associations between Major Depressive Disorder Treatment and Essential Hypertension using Electronic Health Records
por: Pathak, Jyotishman, et al.
Publicado: (2014)

Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients
por: Godlewska, B. R., et al.
Publicado: (2012)

ISPC effect is not observed when the word comes too late: a time course analysis
por: Atalay, Nart B., et al.
Publicado: (2014)

SSRI use and clinical outcomes in epithelial ovarian cancer
por: Christensen, Desiré K., et al.
Publicado: (2016)

Mechanism of Action of N-Acyl and N-Alkoxy Fosmidomycin Analogs: Mono- and Bisubstrate Inhibition of IspC from Plasmodium falciparum, a Causative Agent of Malaria
por: Girma, Misgina B., et al.
Publicado: (2021)

Neonatal SSRI Exposure Programs a Hypermetabolic State in Adult Mice
por: Kummet, Gary J., et al.
Publicado: (2012)

Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram
por: Lash, T L, et al.
Publicado: (2008)

Effects of SSRI treatment on GABA and glutamate levels in an associative relearning paradigm
por: Spurny, B., et al.
Publicado: (2021)

The SSRI Clinic: Improving SSRI Prescribing Safety in Outpatient CAMHS Clinic
por: Morgan, Tammy, et al.
Publicado: (2022)

Multivariate models to detect genomic signatures for a class of drugs: application to thiopurines pharmacogenomics
por: Fridley, B L, et al.
Publicado: (2012)

Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study
por: Biernacka, Joanna M., et al.
Publicado: (2021)

Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics
por: Ji, Yuan, et al.
Publicado: (2012)

Variation in the management of SSRI-exposed babies across England
por: Thomas, Eliza, et al.
Publicado: (2017)

Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs
por: Kato, M, et al.
Publicado: (2015)

Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder
por: Rappaport, Lance M., et al.
Publicado: (2021)

SSRI Facilitated Crack Dancing
por: Doobay, Ravi, et al.
Publicado: (2017)

Nitrous oxide (N(2)O) and subsequent open-label SSRI treatment of adolescents with depression (NOTAD): study protocol for a randomised controlled trial
por: Stewart, Richard M., et al.
Publicado: (2017)

Developmental exposure to the SSRI citalopram causes long-lasting behavioural effects in the three-spined stickleback (Gasterosteus aculeatus)
por: Kellner, M., et al.
Publicado: (2017)

Corrigendum to “Genetic predisposition to major depressive disorder differentially impacts alcohol consumption and high-risk drinking situations in men and women with alcohol use disorder” [Drug Alcohol Depend. 243 (2023) 109753]
por: Karpyak, Victor M., et al.
Publicado: (2023)

Using a pharmacogenomic algorithm to guide the treatment of depression
por: Hall-Flavin, D K, et al.
Publicado: (2012)

Chronic cortisol differentially impacts stem cell-derived astrocytes from major depressive disorder patients
por: Heard, Kelly J., et al.
Publicado: (2021)

Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants
por: Herzallah, Mohammad M., et al.
Publicado: (2013)

The Influence of Acute SSRI Administration on White Matter Microstructure in Patients Suffering From Major Depressive Disorder and Healthy Controls
por: Seiger, R, et al.
Publicado: (2021)

Profiling placental DNA methylation associated with maternal SSRI treatment during pregnancy
por: Inkster, Amy M., et al.
Publicado: (2022)

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication
por: Goodwin, Guy M., et al.
Publicado: (2023)

Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model
por: Lopez-Vilchez, I, et al.
Publicado: (2016)

Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure
por: Williams, Sarah K, et al.
Publicado: (2011)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
por: Ashbury, Janet E., et al.
Publicado: (2012)

Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch
por: Binkhorst, Lisette, et al.
Publicado: (2015)

Pharmacogenomics‐Driven Prediction of Antidepressant Treatment Outcomes: A Machine‐Learning Approach With Multi‐trial Replication
por: Athreya, Arjun P., et al.
Publicado: (2019)

SSRI and Motor Recovery in Stroke: Reestablishment of Inhibitory Neural Network Tonus
por: Pinto, Camila B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r1okb1eiglhnt3lp6qss37hh2g